Logo for Aileron Therapeutics Inc

Aileron Therapeutics Investor Relations Material

Latest events

Logo for Aileron Therapeutics Inc

Study Result

Aileron Therapeutics
Logo for Aileron Therapeutics

Q3 2024

14 Nov, 2024
Logo for Aileron Therapeutics

Study Result

13 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Aileron Therapeutics Inc

Access all reports
Aileron Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative treatments for severe pulmonary and fibrotic diseases, particularly those classified as orphan conditions. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.